Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.
- Published in:
- Gene Therapy, 2008, v. 15, n. 12, p. 921, doi. 10.1038/gt.2008.56
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2008 AND VI 15 AND IP 12
Results: 7
1
2
Gene therapy progress and prospects cancer: oncolytic viruses.
- Published in:
- Gene Therapy, 2008, v. 15, n. 12, p. 877, doi. 10.1038/gt.2008.72
- By:
- Publication type:
- Article
3
A novel magnetic approach to enhance the efficacy of cell-based gene therapies.
- Published in:
- Gene Therapy, 2008, v. 15, n. 12, p. 902, doi. 10.1038/gt.2008.57
- By:
- Publication type:
- Article
4
Wild-type adenoviruses from groups A–F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent.
- Published in:
- Gene Therapy, 2008, v. 15, n. 12, p. 885, doi. 10.1038/gt.2008.18
- By:
- Publication type:
- Article
5
Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA.
- Published in:
- Gene Therapy, 2008, v. 15, n. 12, p. 942, doi. 10.1038/gt.2008.17
- By:
- Publication type:
- Article
6
Improved lentiviral vectors for Wiskott–Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
- Published in:
- Gene Therapy, 2008, v. 15, n. 12, p. 930, doi. 10.1038/gt.2008.20
- By:
- Publication type:
- Article
7
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial.
- Published in:
- Gene Therapy, 2008, v. 15, n. 12, p. 911, doi. 10.1038/gt.2008.21
- By:
- Publication type:
- Article